.png)
.png)
Team Lead (acting), RESP-NET Surveillance Team
CDC
Disclosure(s): No financial relationships to disclose
Fiona Havers, MD, MHS, FIDSA, is a Medical Officer and the Team Lead (acting) for the RESP-NET Surveillance Team (proposed) in the Coronavirus and Other Respiratory Viruses Division (proposed) within the U.S. CDC's National Center for Immunization and Respiratory Diseases (NCIRD). Dr. Havers is the CDC COVID-19 and RSV lead for RESP-NET, a population-based surveillance platforms that collect data on COVID-19, RSV, and influenza-associated hospitalizations.
Dr. Havers earned a Doctor of Medicine from the University of Washington. She completed training in internal medicine and infectious diseases at the Johns Hopkins University. She also obtained a Master’s of Health Science in Epidemiology from the Johns Hopkins Bloomberg School of Public Health and completed the Epidemic Intelligence Service training in the Influenza Division at CDC. She is board certified to practice internal medicine and infectious diseases and is a staff physician at the Atlanta VA Medical Center and an Adjunct Associate Professor in the Emory University Division of Infectious Diseases.
While at CDC, Dr. Havers’ research interests have focused on the epidemiology, prevention, and treatment of vaccine-preventable respiratory diseases, including influenza, pertussis, RSV and SARS-CoV-2. At the start of the COVID-19 pandemic, she led the establishment of large-scale seroprevalence studies before shifting focus to the epidemiology of COVID-19-associated hospitalizations. She was previously the lead for pertussis vaccine policy in the Division of Bacterial Diseases, and prior to that, spent more than 5 years with primary research focused on influenza antiviral treatment, vaccine effectiveness and novel influenza viruses. Dr. Havers is also a commander in the US Public Health Service.